Cargando…
Policy and Practice Review: A First Guideline on the Use of Pharmacogenetics in Clinical Psychiatric Practice
Effective pharmacologic treatments for psychiatric disorders are available, but their effect is limited due to patients’ genetic heterogeneity and low compliance-related to frequent adverse events. Only one third of patients respond to treatment and experience remission. Pharmacogenetics is a relati...
Autores principales: | van Westrhenen, R., van Schaik, R. H. N., van Gelder, T., Birkenhager, T. K., Bakker, P. R., Houwink, E. J. F., Bet, P. M., Hoogendijk, W. J. G., van Weelden-Hulshof, M. J. M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8117336/ https://www.ncbi.nlm.nih.gov/pubmed/33995044 http://dx.doi.org/10.3389/fphar.2021.640032 |
Ejemplares similares
-
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction of DPYD and fluoropyrimidines
por: Lunenburg, Carin A. T. C., et al.
Publicado: (2019) -
Pharmacogenetics and pharmacogenomics: practical applications in routine medical practice
por: Maitland-van der Zee, Anke-Hilse, et al.
Publicado: (2010) -
DPD Testing Before Treatment With Fluoropyrimidines in the Amsterdam UMCs: An Evaluation of Current Pharmacogenetic Practice
por: Martens, Forike K., et al.
Publicado: (2020) -
Clinical Application of Pharmacogenetics: Where are We Now?
por: van Schaik, Ron HN
Publicado: (2014) -
Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
por: Baldacci, Antoine, et al.
Publicado: (2023)